Abstract:Background Epigenetic alternation is a common contributing factor to neoplastic transformation. Although previous studies have reported a cluster of aberrant promoter methylation changes associated with silencing of tumor suppressor genes, little is known concerning their sequential DNA methylation changes during the carcinogenetic process. The aim of the present study was to address a genome-wide search for identifying potentially important methylated changes and investigate the onset and pattern of methylation changes during the progression of colorectal neoplasia. Methods A three-phase design was employed in this study. In the screening phase, DNA methylation profile of 12 pairs of colorectal cancer (CRC) and adjacent normal tissues was analyzed by using the Illumina MethylationEPIC BeadChip. Significant CpG sites were selected based on a cross-validation analysis from The Cancer Genome Atlas (TCGA) database. Methylation levels of candidate CpGs were assessed using pyrosequencing in the training dataset (tumor lesions and adjacent normal tissues from 46 CRCs) and the validation dataset (tumor lesions and paired normal tissues from 13 hyperplastic polyps, 129 adenomas, and 256 CRCs). A linear mixed-effects model was used to examine the incremental changes of DNA methylation during the progression of colorectal neoplasia. Results The comparisons between normal and tumor samples in the screening phase revealed an extensive CRC-specific methylomic pattern with 174,006 (21%) methylated CpG sites, of which 22,232 (13%) were hyermethylated and 151,774 (87%) were hypomethylated. Hypermethylation mostly occurred in CpG islands with an overlap of gene promoters, while hypomethylation tended to be mapped far away from functional regions. Further cross validation analysis from TCGA dataset confirmed 265 hypermethylated promoters coupling with downregulated gene expression. Among which, hypermethylated changes in MEEPD2 promoter was successfully replicated in both training and validation phase. Significant hypermethylation appeared since precursor lesions with an extensive modification in CRCs. The linear mixed-effects modeling analysis found that a cumulative pattern of MPPED2 methylation changes from normal mucosa to hyperplastic polyp to adenoma, and to carcinoma ( P < 0.001). Conclusions Our findings indicate that epigenetic alterations of MPPED2 promoter region appear sequentially during the colorectal neoplastic progression. It might be able to serve as a promising biomarker for early diagnosis and stage surveillance of colorectal tumorigenesis.

The relationship DNA methylation of p16(INK4a) and colorectal cancer

Relationship Between Expression And Methylation Status Of P16(Ink4a) And The Proliferative Activity Of Different Areas' Tumour Cells In Human Colorectal Cancer

Genome-wide methylation profiling identified novel differentially hypermethylated biomarker MPPED2 in colorectal cancer

P16 Gene Methylation in Colorectal Cancers Associated with Duke's Staging.

Exploring the DNA methylome of Korean patients with colorectal cancer consolidates the clinical implications of cancer-associated methylation markers

Association Between P16INK4a Promoter Methylation and Non-Small Cell Lung Cancer: A Meta-Analysis

P16 CpG Region Methylation of the Colorectal Cancer and Its Association with Clinicopathological Characteristics

Association between P16INK4a Promoter Methylation and HNSCC: A Meta-Analysis of 21 Published Studies

IDDF2024-ABS-0362 Dopamine Receptor 4 Hypermethylation: a Multi-Malignant Tumor Marker Plausible for Colorectal Cancer Screening Through Fecal DNA Testing

The specific methylation characteristics of cancer related genes in Chinese colorectal cancer patients

Clinical Significance of Methylation of E-cadherin and P14arf Gene Promoters in Skin Squamous Cell Carcinoma Tissues.

The Hypermethylation and Protein Expression of P16(Ink4a) and Dna Repair Gene O-6-Methylguanine-Dna Methyltransferase in Various Uterine Cervical Lesions

Methylation Status of P16 Gene in Colorectal Carcinoma and Normal Colonic Mucosa.

Detection of aberrant p16 methylation in the serum of colorectal cancer patients

Correlation Between Methylation of the P16 Promoter and Cervical Cancer Incidence.

The Relationship Between Promoter Methylation of P16 Gene and Bladder Cancer Risk: a Meta-Analysis.

Detection Of Methylation Of Human P16(Ink4a) Gene 5 '-Cpg Islands By Electrochemical Method Coupled With Linker-Pcr

The p16 (CDKN2a/INK4a) Tumor-Suppressor Gene in Head and Neck Squamous Cell Carcinoma: A Promoter Methylation and Protein Expression Study in 100 Cases

Detection of Hypermethylation of P16 Gene from Colorectal Cancer Patient

Methylation analysis of cyclin-dependent kinase inhibitor genes in human colorectal cancer cell

Methylation of CpG islands of p16INK4a and cyclinD1 overexpression associated with progression of intraductal proliferative lesions of the breast